fluorescein-5-isothiocyanate has been researched along with Thrombosis in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 7 (38.89) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 2 (11.11) | 24.3611 |
2020's | 4 (22.22) | 2.80 |
Authors | Studies |
---|---|
Alves, NJ; Hall, A; Linnemann, AK; Muralidharan, C; Nallan Chakravarthula, T; Zeng, Z | 1 |
Böhm, A; Grammbauer, S; Greinacher, A; Hafkemeyer, A; Hasan, M; Jedlitschky, G; Moritz, E; Palankar, R; Rauch, BH; Tolksdorf, C; Tzvetkov, MV; Wolf, R | 1 |
Bao, B; Gao, C; Tang, S; Wu, W; Zhang, H; Zhang, T; Zhu, Y | 1 |
Bi, Y; Cao, F; Gao, L; Gao, S; Hou, Y; Hu, Y; Jiang, M; Li, S; Liu, J; Ren, S; Wang, Y; Xu, M; Yang, N; Zhang, J | 1 |
Luan, S; Shi, H; Yan, S; Yin, J; Yuan, S | 1 |
McCrae, K; Merkulov, S; Park, JH; Ruoslahti, E; Sailor, MJ; Simberg, D; Zhang, WM | 1 |
Caravan, P; Chonde, DB; Ciesienski, KL; Loving, GS; Uppal, R | 1 |
Agharkar, P; Chen, B; He, C | 1 |
Herrmann, KS; Voigt, WH | 1 |
Goto, S; Ikeda, Y; Ruggeri, ZM; Salomon, DR | 1 |
Ishii, H; Miyairi, M; Morishita, T; Nagata, H; Sekizuka, E; Tatemichi, M; Tsuchiya, M | 1 |
Edwards, MJ; Lentsch, AB; Miller, FN | 1 |
Aoki, N; Fujimori, Y; Morita, T; Nakamura, F; Omata, M; Sakamoto, Y; Tomaru, T; Uchida, Y | 1 |
Aish, IS; Aish, L; Chishti, AH; Hassoun, H; Liu, SC; Lutchman, M; Palek, J; Vassiliadis, J; Wang, Y | 1 |
Barker, JE; Tait, JF; Wandersee, NJ | 1 |
Goto, S; Handa, S; Ichikawa, N; Ikeda, Y; Kim, JY; Li, M; Sakai, H; Yoshida, M | 1 |
Araki, H; Inoue, M; Jougasaki, M; Muramoto, J; Nishi, K | 1 |
Just, M; Seiffge, D; Tripier, D | 1 |
18 other study(ies) available for fluorescein-5-isothiocyanate and Thrombosis
Article | Year |
---|---|
Fluorescently conjugated annular fibrin clot for multiplexed real-time digestion analysis.
Topics: Crystallization; Fibrin; Fibrinogen; Fluorescein-5-isothiocyanate; Microscopy, Electron, Scanning; Optical Imaging; Thrombosis | 2021 |
Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets.
Topics: Adenosine Diphosphate; ATP-Binding Cassette Transporters; Blood Platelets; Calcium; Fluorescein-5-isothiocyanate; Humans; Integrins; Multidrug Resistance-Associated Proteins; Nucleotides, Cyclic; Signal Transduction; Thrombosis; Thromboxanes | 2022 |
A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator.
Topics: Fibrin; Fluorescein-5-isothiocyanate; Humans; Isoindoles; Pyrans; Thrombosis; Urokinase-Type Plasminogen Activator | 2022 |
A Thrombin-Responsive Nanoprobe for
Topics: Amino Acid Sequence; Animals; Carotid Arteries; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Multimodal Imaging; Peptides; Thrombosis; Tomography, X-Ray Computed | 2021 |
Facile Fabrication of Lubricant-Infused Wrinkling Surface for Preventing Thrombus Formation and Infection.
Topics: Animals; Bacterial Adhesion; Blood Coagulation; Cell Line; Escherichia coli; Fluorescein-5-isothiocyanate; Lubricants; Materials Testing; Mice; Photoelectron Spectroscopy; Platelet Adhesiveness; Rabbits; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Surface Properties; Thrombosis | 2015 |
Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.
Topics: Animals; Blood Proteins; Dextrans; Drug Delivery Systems; Enzyme Activation; Ferric Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Kallikrein-Kinin System; Magnetics; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Weight; Nanoparticles; Thrombosis | 2009 |
Discrete bimodal probes for thrombus imaging.
Topics: Fibrin; Fluorescein-5-isothiocyanate; Gadolinium; Humans; Magnetic Resonance Imaging; Peptides; Positron-Emission Tomography; Thrombosis | 2012 |
Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy.
Topics: Animals; Area Under Curve; Blood Flow Velocity; Blood Vessels; Dextrans; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Male; Microscopy, Fluorescence; Molecular Weight; Perfusion; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Rats; Regional Blood Flow; Thrombosis; Verteporfin | 2008 |
Ultrastructural observations of an electron dense amorphous layer on selectively damaged endothelial cells, a possible trigger of thrombogenesis in vivo, and its inhibition by nafazatrom.
Topics: Animals; Cheek; Cricetinae; Dextrans; Endothelium; Fluorescein-5-isothiocyanate; Fluoresceins; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Pyrazoles; Pyrazolones; Thrombosis | 1984 |
Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets.
Topics: Biomechanical Phenomena; Blood Platelets; Blood Viscosity; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; In Vitro Techniques; Models, Biological; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Solubility; Stress, Mechanical; Thrombin; Thrombosis; von Willebrand Factor | 1995 |
Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy.
Topics: Animals; Capillary Permeability; Endoscopy, Gastrointestinal; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Hemostasis; Hemostatics; Intestinal Mucosa; Male; Oleic Acids; Polidocanol; Polyethylene Glycols; Rats; Rats, Wistar; Sclerosing Solutions; Sclerotherapy; Serum Albumin, Bovine; Thrombosis; Veins | 1996 |
Interleukin-2 induces increased platelet-endothelium interactions: a potential mechanism of toxicity.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Cattle; Collagen; Ear; Endothelium, Vascular; Fluorescein-5-isothiocyanate; Interleukin-2; Light; Lymphocyte Function-Associated Antigen-1; Male; Mice; Mice, Inbred C57BL; Microcirculation; Platelet Aggregation; Serum Albumin, Bovine; Thrombosis | 1996 |
Local delivery of antithrombotic drug prevents restenosis after balloon angioplasty in atherosclerotic rabbit artery.
Topics: Angiography; Angioplasty, Balloon, Coronary; Angioscopy; Animals; Antithrombins; Arginine; Arteriosclerosis; Batroxobin; Constriction, Pathologic; Fibrinolytic Agents; Fluorescein-5-isothiocyanate; Heparin, Low-Molecular-Weight; Iliac Artery; Male; Microscopy, Confocal; Pipecolic Acids; Rabbits; Sulfonamides; Thrombosis | 1996 |
Targeted inactivation of murine band 3 (AE1) gene produces a hypercoagulable state causing widespread thrombosis in vivo.
Topics: Animals; Anion Exchange Protein 1, Erythrocyte; Annexin A5; Blood Coagulation; Erythrocyte Membrane; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gene Targeting; Membrane Lipids; Mice; Mice, Mutant Strains; Microscopy, Fluorescence; Phosphatidylserines; Thrombosis | 1998 |
Erythroid phosphatidyl serine exposure is not predictive of thrombotic risk in mice with hemolytic anemia.
Topics: Age Factors; Anemia, Hemolytic; Animals; Animals, Newborn; Annexin A5; Cell Size; Erythrocyte Membrane; Erythrocytes; Flow Cytometry; Fluorescein-5-isothiocyanate; Lipid Bilayers; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Phosphatidylserines; Spectrin; Thrombosis | 2000 |
Enhanced shear-induced von Willebrand factor binding to platelets in acute myocardial infarction.
Topics: Aged; Antibodies, Monoclonal; Blood Platelets; Chest Pain; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Male; Middle Aged; Myocardial Infarction; Plasma; Platelet Activation; Protein Binding; Stress, Mechanical; Thrombosis; von Willebrand Factor | 2000 |
Heparin adheres to the damaged arterial wall and inhibits its thrombogenicity.
Topics: Animals; Arteries; Disease Models, Animal; Extracellular Matrix; Fluorescein-5-isothiocyanate; Heparin; Injections, Intra-Arterial; Injections, Intravenous; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Thrombosis | 1992 |
Antithrombotic effects of recombinant hirudin in different animal models.
Topics: Animals; Arterial Occlusive Diseases; Bleeding Time; Carotid Artery Thrombosis; Dextrans; Disease Models, Animal; Fluorescein-5-isothiocyanate; Fluoresceins; Hirudin Therapy; Jugular Veins; Lasers; Male; Mesenteric Arteries; Photochemistry; Rabbits; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Recombinant Proteins; Thrombosis; Venae Cavae | 1991 |